GC Biopharma Corp. (006280.KS)
GC Biopharma Corp., a biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.
115,900.00+0.01%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-15.6%
The outlook
GC Biopharma Corp. currently reads as neutral based on buy — 1.6 avg of 8 analysts, below its 50- & 200-day averages, 10% of the way from its 52-week low to high, avg target +71% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusBuy — 1.6 avg of 8 analysts
Price trendBelow its 50- & 200-day averages
52-week range10% of the way from its 52-week low to high
Price targetAvg target +71% vs current price
Analyst price target
~12-month · 8 analysts198,500.00average target+71.3% vs now
Now 115,900.00
Low 165,000.00High 230,000.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.32T
52-wk high
183,800.00
52-wk low
108,100.00
50-day avg
125,850.00
200-day avg
142,968.50
Trailing P/E
—